Alan I. Annex
Direktor/Vorstandsmitglied bei Merand Pharmaceuticals, Inc.
Aktive Positionen von Alan I. Annex
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Merand Pharmaceuticals, Inc.
 Merand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merand Pharmaceuticals, Inc. engages in the provision of therapeutic products. It is developing a novel microRNA therapeutic (MicroRNA93 or miR-93) to treat patients suffering from Peripheral Arterial Disease (PAD). The company was founded in 2018 and is headquartered in Charlottesville, VA. | Direktor/Vorstandsmitglied | - | - |
| Unternehmenssekretär | - | - |
Karriereverlauf von Alan I. Annex
Statistik
International
| Vereinigte Staaten | 2 |
Operativ
| Director/Board Member | 1 |
| Corporate Secretary | 1 |
Sektoral
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Merand Pharmaceuticals, Inc.
Merand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merand Pharmaceuticals, Inc. engages in the provision of therapeutic products. It is developing a novel microRNA therapeutic (MicroRNA93 or miR-93) to treat patients suffering from Peripheral Arterial Disease (PAD). The company was founded in 2018 and is headquartered in Charlottesville, VA. | Health Technology |
- Börse
- Insiders
- Alan I. Annex
- Erfahrung
